Philip Noone

5 results

Philip Noone, Aalto Bio: ‘While the initial concern surrounding the Zika virus has subsided, there are still outbreaks together with ongoing Dengue and Chikungunya epidemics that mean a continual demand for these raw materials.’

In the five years since he acquired Aalto Bio, Philip Noone has had remarkable success, gaining a foothold as the market leader in the diagnosis of th(...)

One of the largest outbreaks of the virus occurred in Colombia in 1995.  Photograph: iStock

A Dublin-based provider of raw materials to the pharmaceutical industry has launched a product to detect and diagnose an infectious disease known as V(...)

Pictured at the announcement of this year’s finalists are Kevin McLoughlin, EY partner lead for the awards programme, and Anne Heraty, chief executive of Cpl Resources and chair of the judging panel

The shortlist for the 2019 EY Entrepreneur of the Year awards has been announced with Supermac’s founder Pat McDonagh and Matt Ryan of hospitality gro(...)

BrainWaveBank headset: the device’s sensors collect cognitive data while users play games on a smartphone

Aalto Bio Reagents Aalto Bio Reagents is an Irish company playing a global role in tackling serious tropical viruses such as Zika, dengue and yellow (...)

Aalto Bio Reagents CEO Philip Noone. Photograph: Conor McCabe

Aalto Bio Reagents is an Irish company playing a global role in tackling serious tropical viruses such as Zika, dengue and yellow fever. Founded in 1(...)